Recent product introductions under the LMA ® brand from Teleflex focus on giving the physician enhanced control of the airway throughout the use of anesthetic.

--Teleflex Incorporated, a leading global provider of medical technologies, today announced U.S. Food and Drug Administration 510 clearance of an expansion to the Indications for Use of the ...

Teleflex, which employs approximately 12,600 people worldwide, also has niche businesses that serve segments of the aerospace and commercial markets with specialty engineered products.

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the Indications for Use of its QuikClot Control+ ...

Teleflex receives FDA clearance to expand QuikClot Control+™ device indications for all grades of bleeding, enhancing patient care.

WAYNE, Pa., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that two new UroLift System products, the UroLift Advanced Tissue Control (ATC) System and the ...

WAYNE, Pa., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the expansion of its UroLift® System portfolio with the introduction of the UroLift® Advanced ...

WAYNE, Pa., May 13, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX), a leading global provider of medical technologies, today announced the full U.S. commercial launch of its UroLift ® 2 ...

Given the importance of Teleflex products to health outcomes, product issues (either related to quality control or manufacturing) should be prevented to avoid social ESG concerns.

Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies for critical care and surgery, has a rich history of innovation focused on solving unmet clinical needs. Recent ...